Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
297.5 GBX | -2.14% | +2.59% | +5.12% |
Apr. 26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
Apr. 26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.12% | 3.26B | |
+33.59% | 664B | |
+29.29% | 567B | |
-7.50% | 354B | |
+18.42% | 330B | |
+4.54% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.67% | 148B |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- Hutchmed to Present New Data at US Cancer Research Conference